相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward
Francesco Panza et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The worldwide economic impact of dementia 2010
Anders Wimo et al.
ALZHEIMERS & DEMENTIA (2013)
Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization
Elina Zotova et al.
BRAIN (2013)
Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease
Paul S. Aisen et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Cerebrospinal Fluid PKR Level Predicts Cognitive Decline in Alzheimer's Disease
Julien Dumurgier et al.
PLOS ONE (2013)
Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
Susanne Ostrowitzki et al.
ARCHIVES OF NEUROLOGY (2012)
Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
Kaj Blennow et al.
ARCHIVES OF NEUROLOGY (2012)
Increased Cerebrospinal Fluid Levels of Double-Stranded RNA-Dependant Protein Kinase in Alzheimer's Disease
Francois Mouton-Liger et al.
BIOLOGICAL PSYCHIATRY (2012)
The PKR Activator PACT Is Induced by Aβ: Involvement in Alzheimer's Disease
Claire Paquet et al.
BRAIN PATHOLOGY (2012)
Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice
Dimitrije Krstic et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling et al.
LANCET NEUROLOGY (2012)
Modulation of Tau Phosphorylation by the Kinase PKR: Implications in Alzheimer's Disease
Anindita Bose et al.
BRAIN PATHOLOGY (2011)
Microglial alterations in human Alzheimer's disease following Aβ42 immunization
E. Zotova et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Aβ42 immunisation in Alzheimer's disease
Delphine Boche et al.
ACTA NEUROPATHOLOGICA (2010)
Beneficial effect of human anti-amyloid-β active immunization on neurite morphology and tau pathology
Alberto Serrano-Pozo et al.
BRAIN (2010)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
The biochemical aftermath of anti-amyloid immunotherapy
Chera L. Maarouf et al.
MOLECULAR NEURODEGENERATION (2010)
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Stephanie J. Soscia et al.
PLOS ONE (2010)
Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
Bruno Vellas et al.
CURRENT ALZHEIMER RESEARCH (2009)
The amyloid hypothesis for Alzheimer's disease: a critical reappraisal
John Hardy
JOURNAL OF NEUROCHEMISTRY (2009)
Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake
Shaomin Li et al.
NEURON (2009)
Consequence of A immunization on the vasculature of human Alzheimers disease brain
D. Boche et al.
BRAIN (2008)
Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation
Jae Woong Lee et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
The dsRNA protein kinase PKR:: Virus and cell control
M. A. Garcia et al.
BIOCHIMIE (2007)
Aβ species removal after Aβ42 immunization
James A. R. Nicoll et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Amyloid-β peptide remnants in AN-1792-immunized Alzheimer's disease patients -: A biochemical analysis
R. Lyle Patton et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
β-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease
M Buttini et al.
JOURNAL OF NEUROSCIENCE (2005)
Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
NC Fox et al.
NEUROLOGY (2005)
Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD
AJ Bayer et al.
NEUROLOGY (2005)
Neuronal structure is altered by amyloid plaques
TL Spires et al.
REVIEWS IN THE NEUROSCIENCES (2004)
Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in β-amyloid peptide neurotoxicity
KC Suen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
JM Orgogozo et al.
NEUROLOGY (2003)
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide:: a case report
JAR Nicoll et al.
NATURE MEDICINE (2003)
Neuropathology of cognitively normal elderly
DS Knopman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2α in neuronal degeneration
RCC Chang et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
C Janus et al.
NATURE (2000)
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
D Morgan et al.
NATURE (2000)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
分享论文
